erlotinib hydrochloride has been researched along with adenine in 4 studies
Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (adenine) | Trials (adenine) | Recent Studies (post-2010) (adenine) |
---|---|---|---|---|---|
4,353 | 786 | 3,033 | 21,903 | 1,153 | 7,682 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dai, B; Fang, B; Gao, W; Gold, KA; Heymach, JV; Hofstetter, WL; Lu, H; Minna, J; Ou, Z; Roth, JA; Swisher, SG; Wang, L; Wang, M; Wu, S; Zhang, L | 1 |
Bekerman, E; Einav, S | 1 |
Huang, K; Liu, D | 1 |
Byström, S; Daneshmanesh, AH; Ghaderi, A; Hansson, L; Hojjat-Farsangi, M; Mellstedt, H; Moshfegh, A; Olin, T; Olsson, E; Österborg, A; Schultz, J; Vågberg, J | 1 |
4 other study(ies) available for erlotinib hydrochloride and adenine
Article | Year |
---|---|
Selective antitumor activity of ibrutinib in EGFR-mutant non-small cell lung cancer cells.
Topics: Adenine; Animals; Antineoplastic Agents; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Methionine; Mice; Mutation; Piperidines; Pyrazoles; Pyrimidines; Quinazolines; Threonine | 2014 |
Infectious disease. Combating emerging viral threats.
Topics: Adenine; Adenosine; Antiviral Agents; Benzamides; Chloroquine; Communicable Diseases, Emerging; Cyclosporins; Cytosine; Dengue; Drug Approval; Drug Design; Erlotinib Hydrochloride; Hemorrhagic Fever, Ebola; Humans; Imatinib Mesylate; Indoles; Organophosphonates; Piperazines; Purine Nucleosides; Pyrimidines; Pyrroles; Pyrrolidines; Quinazolines; Sunitinib; Viruses | 2015 |
Targeting non-canonical autophagy overcomes erlotinib resistance in tongue cancer.
Topics: Adenine; Antineoplastic Combined Chemotherapy Protocols; Autophagy; Autophagy-Related Protein 5; Beclin-1; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Erlotinib Hydrochloride; Humans; Hydroxychloroquine; RNA, Small Interfering; Sirolimus; Tongue Neoplasms; Up-Regulation | 2016 |
A receptor tyrosine kinase ROR1 inhibitor (KAN0439834) induced significant apoptosis of pancreatic cells which was enhanced by erlotinib and ibrutinib.
Topics: Adenine; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Drug Synergism; Erlotinib Hydrochloride; Gene Expression Regulation, Neoplastic; Humans; Low Density Lipoprotein Receptor-Related Protein-6; Organic Chemicals; Pancreas; Pancreatic Neoplasms; Phosphorylation; Piperidines; Protein Kinase Inhibitors; Protein Multimerization; Protein Structure, Quaternary; Pyrazoles; Pyrimidines; Receptor Tyrosine Kinase-like Orphan Receptors | 2018 |